Cargando…
Metformin use and prostate cancer in Caucasian men: results from a population-based case–control study
PURPOSE: Metformin is a commonly used medication for type II diabetes mellitus. Epidemiologic studies have suggested a decreased relative risk of cancer with metformin use, and preclinical studies of prostate cancer (PCa) have shown antitumor activity with metformin. In this study, we explore the re...
Autores principales: | Wright, Jonathan L., Stanford, Janet L. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer Netherlands
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767519/ https://www.ncbi.nlm.nih.gov/pubmed/19653109 http://dx.doi.org/10.1007/s10552-009-9407-y |
Ejemplares similares
-
Comparison of germline mutations in African American and Caucasian men with metastatic prostate cancer
por: Ledet, Elisa M., et al.
Publicado: (2021) -
Genetic and Molecular Differences in Prostate Carcinogenesis between African American and Caucasian American Men
por: Farrell, James, et al.
Publicado: (2013) -
Metformin reduces prostate cancer risk among men with benign prostatic hyperplasia: A nationwide population‐based cohort study
por: Kuo, Yu‐Jui, et al.
Publicado: (2019) -
Metformin Treatment Among Men With Diabetes and the Risk of Prostate Cancer: A Population-Based Historical Cohort Study
por: Freedman, Laurence S, et al.
Publicado: (2021) -
Survival analysis in Caucasian pulmonary adenocarcinoma patients based on differential targets between Caucasian and Asian population
por: Zhu, Zheng, et al.
Publicado: (2018)